Warnings
Pregnancy and lactation
Studies of Kestine in rats and rabbits do not indicate any direct or indirect harmful effects with respect to the development of the embryo or foetus, or the course of gestation and pre- and post-natal development. No teratogenic effects have been identified in animals. However, there are no well controlled studies in pregnant women and reproductive studies in animals are not always predictive of human response. Therefore, Kestine should be used during pregnancy only if clearly needed. It is not known, whether ebastine is excreted in human milk, therefore, Kestine should not be used during lactation.
Interactions
Kestine can interfere with the results of dermal allergic tests and therefore, it is recommended not to perform these tests until 5 - 7 days after treatment discontinuation. It could strengthen the effects of other anti-histaminic agents.
Incompatabilities
Up to date, none have been described
Use in Children
Kestine must not be administered to children under 2 years old, since safety has not been established in this age group.
